REVIEW

1. Hepatitis E in immunocompromised individuals

MINIREVIEWS

1. Small duct primary sclerosing cholangitis:A discrete variant or a bridge to large duct disease,a practical review
2. New progress in understanding roles of nitric oxide during hepatic ischemia-reperfusion injury
3. Renal manifestations of hepatitis E among immunocompetent and solid organ transplant recipients
4. Safety of direct acting antiviral treatment for hepatitis C in oncologic setting:A clinical experience and a literature review

ORIGINAL ARTICLE

1. Fertaric acid amends bisphenol A-induced toxicity,DNA breakdown,and histopathological changes in the liver,kidney,and testis
2. Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease:A population-based study
3. Standards of liver cirrhosis care in Central Australia
4. Risk factors and prediction of acute kidney injury after liver transplantation:Logistic regression and artificial neural network approaches
5. Pediatric liver transplantation outcomes from a single center in Thailand
6. Predictors of Mortality at 28-days in lnfection associated Acute Kidney lnjury in Cirrhosis
7. Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy
8. lnterrelationship between physical activity and depression in nonalcoholic fatty liver disease
9. Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma
10. Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment